stella
beta
Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer — Stella
Recruiting
Back to Triple Negative Breast Neoplasms trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
Japan
Gifu University Hospital, Gifu, Gifu
Okayama University Hospital, Okayama
St. Luke's International Hospital, Tokyo
View full record on ClinicalTrials.gov